Glycated Hemoglobin Testing System

Diagnostic testing for glycated hemoglobin measurement, providing assessment of long-term glucose control and diabetes monitoring. Results reflect average blood glucose levels over two to three months.

In vitro diagnostic test for measurement of glycated hemoglobin (HbA1c) used for diabetes diagnosis and monitoring. This test provides assessment of long-term blood glucose control over a 2-3 month period.

Chairside glycemic control monitoring test for diabetes management and metabolic assessment. Delivers results in minutes for immediate patient counseling and treatment planning.

Portable blood glucose meter system for point-of-care testing in clinical and home settings for diabetes management.

Multi-functional diagnostic system for measuring hemoglobin levels in blood. The device supports anemia screening and general hematological assessment in home and clinical environments.

Point-of-care testing system for rapid blood glucose measurement. Designed for hospital, clinic, and pharmacy settings requiring quick glucose monitoring results.

A diagnostic test kit for measuring glycated hemoglobin levels using fluorescence immunochromatography technology. It is used for diabetes screening and monitoring in point-of-care testing settings.

Blood glucose monitoring system for diabetes management and routine clinical screening. The GH22 provides rapid glucose measurement from capillary or venous blood samples with digital display results. Designed for point-of-care testing in clinical settings, laboratories, and patient self-monitoring applications.

Antigen and antibody reagents for glycated hemoglobin detection used in diabetes diagnostic testing. These components enable quantitative measurement of long-term blood glucose control in clinical laboratory settings.

Automated glycated hemoglobin testing reagent for diabetes monitoring and diagnosis. Used in clinical laboratories to measure long-term blood glucose control in patients.

Point-of-care testing analyzer for hemoglobin A1c measurement, enabling rapid diabetes monitoring and glycemic control assessment in clinical settings. Delivers quantitative HbA1c results from capillary or venous blood samples within minutes, supporting immediate clinical decision-making in hospitals and outpatient clinics.

Point-of-care testing analyzer for rapid HbA1c measurement, enabling immediate glycemic control assessment in clinical settings. This diagnostic device delivers quantitative hemoglobin A1c results within minutes, supporting diabetes screening and management at bedside or in primary care facilities.